跳至主要内容
临床试验/KCT0008457
KCT0008457招募中Unknown

Prospective observational study to identify efficacy of induction treatments consist of bortezomib-lenalidomide-dexamethasone in transplant-eligible newly diagnosed multiple myeloma

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1)Patients over 19 years old
  • 2)Patients diagnosed with multiple myeloma in need of treatment
  • 3)Patients planning VRD combination therapy and subsequent autologous hematopoietic stem cell transplantation according to ITT's plan

排除标准

  • 1) Neutrophil count <1,000/mm3 at the time of study registration
  • 2) Platelet count <80,000/mm3 at the time of study registration
  • 3) a pregnant woman or a lactating woman

研究者

相似试验